SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037611
Filing Date
2023-08-03
Accepted
2023-08-03 08:14:08
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prld-20230630.htm   iXBRL 10-Q 2052094
2 EX-3.1 prld-ex3_1.htm EX-3.1 75296
3 EX-31.1 prld-ex31_1.htm EX-31.1 21073
4 EX-31.2 prld-ex31_2.htm EX-31.2 21099
5 EX-32.1 prld-ex32_1.htm EX-32.1 11830
6 EX-32.2 prld-ex32_2.htm EX-32.2 12024
  Complete submission text file 0000950170-23-037611.txt   7416646

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prld-20230630_pre.xml EX-101.PRE 264640
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prld-20230630_cal.xml EX-101.CAL 36522
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prld-20230630_lab.xml EX-101.LAB 354166
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prld-20230630.xsd EX-101.SCH 38828
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prld-20230630_def.xml EX-101.DEF 162348
53 EXTRACTED XBRL INSTANCE DOCUMENT prld-20230630_htm.xml XML 1436853
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 231138209
SIC: 2834 Pharmaceutical Preparations